Literature DB >> 1752976

Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1752976      PMCID： PMC496623          DOI： 10.1136/jcp.44.11.885

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  18 in total

1.  Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants.

Authors:  T Exner; D A Triplett; D Taberner; S J Machin
Journal:  Thromb Haemost       Date:  1991-03-04       Impact factor: 5.249

2.  A clinical study of the lupus anticoagulant.

Authors:  M A Schleider; R L Nachman; E A Jaffe; M Coleman
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

3.  The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants.

Authors:  P Thiagarajan; V Pengo; S S Shapiro
Journal:  Blood       Date:  1986-10       Impact factor: 22.113

Review 4.  An immune mechanism in thrombosis.

Authors:  G R Hughes
Journal:  Q J Med       Date:  1988-10

Review 5.  Laboratory identification of the lupus anticoagulant.

Authors:  D A Triplett; J Brandt
Journal:  Br J Haematol       Date:  1989-10       Impact factor: 6.998

6.  Relative sensitivity of different tests in the detection of low titer lupus anticoagulants.

Authors:  B Lesperance; M David; J Rauch; C Infante-Rivard; G E Rivard
Journal:  Thromb Haemost       Date:  1988-10-31       Impact factor: 5.249

7.  Comparison of two simple tests for the lupus anticoagulant.

Authors:  T Exner
Journal:  Am J Clin Pathol       Date:  1985-02       Impact factor: 2.493

8.  The "primary" antiphospholipid syndrome: major clinical and serological features.

Authors:  R A Asherson; M A Khamashta; J Ordi-Ros; R H Derksen; S J Machin; J Barquinero; H H Outt; E N Harris; M Vilardell-Torres; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

9.  Comparison of laboratory tests used for identification of the lupus anticoagulant.

Authors:  S C Lo; M J Oldmeadow; M A Howard; B G Firkin
Journal:  Am J Hematol       Date:  1989-04       Impact factor: 10.047

10.  The reliability of activated partial thromboplastin time methods and the relationship to lipid composition and ultrastructure.

Authors:  K J Stevenson; A C Easton; A Curry; J M Thomson; L Poller
Journal:  Thromb Haemost       Date:  1986-04-30       Impact factor: 5.249
View more
  10 in total

Review 1.  Antiphospholipid syndrome: laboratory testing and diagnostic strategies.

Authors:  Thomas L Ortel
Journal:  Am J Hematol       Date:  2012-03-31       Impact factor: 10.047

Review 2.  Detection of lupus anticoagulants.

Authors:  M H Horellou; M M Samama
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 3.  Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion.

Authors:  M A Khamashta; G R Hughes
Journal:  Clin Rev Allergy       Date:  1994

Review 4.  Laboratory diagnosis of the lupus anticoagulant.

Authors:  Thomas L Ortel
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

5.  Prevalence and Resolution of Lupus Anticoagulant in Children.

Authors:  Chandra Kallanagowdar; Aman Chauhan; Mora V Puertolas; Rajasekharan Warrier
Journal:  Ochsner J       Date:  2016

6.  Marginal zone lymphoma-associated antiphospholipid antibodies successfully treated with bendamustine rituximab.

Authors:  Ziyang Liu; Merry Markham; Molly W Mandernach
Journal:  BMJ Case Rep       Date:  2019-03-14

Review 7.  Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances.

Authors:  Arne Vandevelde; Katrien M J Devreese
Journal:  J Clin Med       Date:  2022-04-13       Impact factor: 4.964

8.  Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene.

Authors:  Eva M Jacobsen; Elin J Trettenes; Finn Wisløff; Ulrich Abildgaard
Journal:  Thromb J       Date:  2006-01-25

9.  A novel mutation in exon 2 of FGB caused by c.221G>T † substitution, predicting the replacement of the native Arginine at position 74 with a Leucine (p.Arg74Leu † ) in a proband from a Kurdish family with dysfibrinogenaemia and familial venous and arterial thrombosis.

Authors:  Abdul A Shlebak; Alexia D Katsarou; George Adams; Fiona Fernando
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300

10.  Application of different lupus anticoagulant diagnostic algorithms to the same assay data leads to interpretive discrepancies in some samples.

Authors:  Gary W Moore; James C Maloney; Naomi de Jager; Clare L Dunsmore; Dervilla K Gorman; Richard F Polgrean; Maria L Bertolaccini
Journal:  Res Pract Thromb Haemost       Date:  2017-06-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.